Virginia Albanese Appointed to CDW Board of Directors
Mar 03, 2016 21:05 pm UTC| Business
LINCOLNSHIRE, Ill., March 03, 2016 -- CDW (NASDAQ:CDW), a leading provider of technology solutions to business, government, education and healthcare, today announced that Virginia Albanese has been appointed to the...
Ambarella, Inc. Announces Fourth Quarter and Fiscal Year 2016 Financial Results
Mar 03, 2016 21:05 pm UTC| Business
SANTA CLARA, Calif., March 03, 2016 -- Ambarella, Inc. (NASDAQ:AMBA), a leading developer of low-power, HD and Ultra HD video compression and image processing semiconductors, today announced financial results for its...
Mar 03, 2016 21:01 pm UTC| Business
LEESBURG, Va., March 03, 2016 -- K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex...
Broadcom Limited Announces First Quarter Fiscal Year 2016 Financial Results
Mar 03, 2016 21:01 pm UTC| Business
Quarterly GAAP gross margin of 53 percent; Quarterly non-GAAP gross margin from continuing operations of 61 percentQuarterly GAAP diluted EPS of $1.30; Quarterly non-GAAP diluted EPS from continuing operations of $2.41SAN...
Dan Juckniess Joins SPS Commerce as Chief Sales Officer
Mar 03, 2016 21:01 pm UTC| Business
MINNEAPOLIS, March 03, 2016 -- SPS Commerce, Inc. (Nasdaq:SPSC), a leader in retail cloud services, announced that Dan Juckniess has joined the company’s executive team as Chief Sales Officer. In this new position, he...
The Michaels Companies, Inc. to Report Fourth Quarter and Full Year Results on March 17, 2016
Mar 03, 2016 21:01 pm UTC| Business
IRVING, Texas, March 03, 2016 -- The Michaels Companies, Inc. (NASDAQ:MIK) today announced that it will report its fourth quarter and full year results prior to market open on Thursday, March 17, 2016. In connection...
Fate Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results
Mar 03, 2016 21:01 pm UTC| Business
ProTmune™ Investigational New Drug Application for Prevention of Acute GvHD and CMV Infection Cleared by FDA in January 2016 Phase 1/2 Clinical Trial of ProTmune to Commence Enrollment in mid-2016 Data Updates for All...